azelastine has been researched along with gsk 1004723 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browning, C; Buckley, JM; Clark, KL; Fechner, L; Gore, PM; Hancock, AP; Hodgson, ST; Holmes, DS; Kranz, M; Looker, BE; Morriss, KM; Parton, DL; Procopiou, PA; Russell, LJ; Slack, RJ; Sollis, SL; Vile, S; Watts, CJ | 1 |
| Browning, C; Gore, PM; Lynn, SM; Procopiou, PA; Richards, SA; Slack, RJ; Sollis, SL | 1 |
| Ancliff, RA; Gore, PM; Hancock, AP; Hodgson, ST; Holmes, DS; Keeling, SP; Looker, BE; Parr, NA; Procopiou, PA; Rowedder, JE; Slack, RJ | 1 |
3 other study(ies) available for azelastine and gsk 1004723
| Article | Year |
|---|---|
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.
Topics: Administration, Intranasal; Administration, Oral; Drug Discovery; Histamine H1 Antagonists; Histamine H3 Antagonists; Humans; Models, Molecular; Phthalazines; Protein Conformation; Receptors, Histamine H1; Receptors, Histamine H3; Rhinitis | 2011 |
Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Histamine H1 Antagonists; Humans; Phthalazines; Protein Binding; Pyrazines; Pyridazines; Pyridines; Receptors, Histamine H1; Stereoisomerism; Structure-Activity Relationship | 2012 |
The discovery of quinoline based single-ligand human H
Topics: Dose-Response Relationship, Drug; Drug Discovery; Histamine H1 Antagonists; Histamine H3 Antagonists; Humans; Ligands; Molecular Structure; Quinolines; Receptors, Histamine H1; Receptors, Histamine H3; Structure-Activity Relationship | 2016 |